BBP vs. GERM

Last updated Jun 24, 2026

BBP (Virtus LifeSci Biotech Products ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - BBP tracks the LifeSci Biotechnology Products Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, BBP returned 59.95% vs 0.00% for GERM. BBP charges 0.79%/yr vs 0.68%/yr for GERM.

Performance

BBP vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BBP

• 1D: 1.20%
• 1M: 7.69%
• YTD: 16.04%
• 6M: 14.38%
• 1Y: 59.95%
• 3Y*: 20.40%
• 5Y*: 11.34%
• 10Y*: 13.69%

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. GERM - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BBP Virtus LifeSci Biotech Products ETF	16.04%	33.15%	-3.75%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%

BBP vs. GERM - Sectors Allocation Comparison

Sectors	BBP	GERM
Healthcare	100.0%	99.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	0.4%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BBP vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP

BBP Risk / Return Rank: 85
BBP Sharpe Ratio Rank: 84
BBP Sortino Ratio Rank: 82
BBP Omega Ratio Rank: 73
BBP Calmar Ratio Rank: 94
BBP Martin Ratio Rank: 91

GERM

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BBP	GERM	Difference
Sharpe ratio: Return per unit of total volatility	2.52	—	—
Sortino ratio: Return per unit of downside risk	3.42	—	—
Omega ratio: Gain probability vs. loss probability	1.40	—	—
Calmar ratio: Return relative to maximum drawdown	6.49	—	—
Martin ratio: Return relative to average drawdown	20.18	—	—

Drawdowns

BBP vs. GERM - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BBP and GERM.

Drawdown Indicators

	BBP	GERM	Difference
Max Drawdown Largest peak-to-trough decline	-44.32%	0.00%	-44.32%
Max Drawdown (1Y) Largest decline over 1 year	-9.28%	0.00%	-9.28%
Max Drawdown (3Y) Largest decline over 3 years	-26.09%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-37.89%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-44.32%	—	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-11.98%	0.00%	-11.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.98%	0.00%	+2.98%

Volatility

BBP vs. GERM - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 6.46% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBP	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.46%	0.00%	+6.46%
Volatility (6M) Calculated over the trailing 6-month period	18.88%	0.00%	+18.88%
Volatility (1Y) Calculated over the trailing 1-year period	23.96%	0.00%	+23.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.37%	0.00%	+26.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.39%	0.00%	+27.39%

BBP vs. GERM - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than GERM's 0.68% expense ratio.

Dividends

BBP vs. GERM - Dividend Comparison

Neither BBP nor GERM has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBP Virtus LifeSci Biotech Products ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.00%	1.29%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Which is riskier, BBP or GERM?

BBP has higher volatility (6.46%) compared to GERM (0.00%). In terms of maximum drawdown, BBP dropped -44.32% vs GERM's 0.00%.

Which ETF is better, BBP or GERM?

On 1-year performance, BBP leads with 59.95% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BBP or GERM?

Over the 1-year period, BBP has performed better with a 59.95% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BBP or GERM?

GERM is cheaper with a 0.68% expense ratio, compared with 0.79% for BBP.

Which ETF pays a higher dividend yield, BBP or GERM?

BBP and GERM have nearly identical dividend yields, around 0.00%.

What is the main difference between BBP and GERM?

BBP tracks LifeSci Biotechnology Products Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: Virtus Investment Partners and Amplify. Their fees differ too: 0.79% for BBP and 0.68% for GERM.